Clinical Trials on Volunteer Subjects

Total 4741 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics of Ascending Single IV Doses of ERB-257

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

Healthy Subjects

United States
University of Applied Sciences of Western Switzerland

Completed

Combination of Strength and Sensorimotor Training

Healthy Subjects

Switzerland
Ruhr University of Bochum

Completed

Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers

Healthy Subjects

Germany
American University

Completed

The Effects of Coffee

Healthy Subjects

United States
Avigen

Completed

Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650

Healthy Subjects

United States
Technische Universität Dresden

Completed

Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.

Healthy Subjects

Germany
Yale University
American Heart Association

Completed

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

Healthy Subjects

United States
Pfizer

Completed

Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery (FCAD02)

Cardiac Surgery Subjects | Subjects Undergoing CABG and/or Cardiac Valve Replacement

United States
University Hospital, Clermont-Ferrand

Recruiting

Optimisation of Eccentric Exercises (OPTIMEX)

Healthy Control Subjects

France
China Resources Biopharmaceutical Co., Ltd
Peking University Third Hospital

Recruiting

A Trial of CRB4101 in Healthy Subjects

Healthy Adult Subjects

China
Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

A Clinical Trial of XZP-3287 for Material Balance

Healthy Male Subjects

China
Enzene Biosciences Ltd.
Alkem Laboratories Ltd

Recruiting

Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

Healthy Male Subjects

Bulgaria, Poland
Kyowa Kirin, Inc.

Completed

Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356

Healthy Male Subjects

United States
Auzone Biological Technology Pty Ltd

Completed

Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects

Healthy Adult Subjects

United States
Bio-Thera Solutions
Wuhan Union Hospital, China

Active, not recruiting

Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects

Healthy Male Subjects

China
Bloomage Biotechnology Corp., Ltd.

Completed

The Effect of Oral Hyaluronic Acid on the Skin

Healthy Japanese Subjects

Japan
Reata, a wholly owned subsidiary of Biogen

Completed

A Human AME Study for Omaveloxolone

Healthy Male Subjects

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

Healthy Adult Subjects

Japan
Alvotech Swiss AG
Iqvia Pty Ltd

Completed

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

Healthy Adult Subjects

New Zealand, United Kingdom
Halia Therapeutics, Inc.
TKL Research, Inc.

Completed

Study to Evaluate HT-6184 in Healthy Subjects

Normal Healthy Subjects

United States
Taiho Pharmaceutical Co., Ltd.

Completed

A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects

Healthy Male Subjects

Japan
GE Healthcare
PPD

Completed

A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.

Healthy Subjects (HS)

China
Darnitsa Pharmaceutical Company
ACDIMA Biocenter

Completed

Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Darnitsa Pharmaceutical Company
ACDIMA Biocenter

Completed

Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers

Healthy Adult Subjects

China
Spanish National Research Council
Andalusian Health Service; Universidad Pablo de Olavide

Completed

Bioavailability of Oleanolic Acid Formulated as Functional Olive Oil (BIO-OLTRAD)

Healthy Subjects | Bioavailability

Spain
Taisho Pharmaceutical Co., Ltd.

Completed

Mass Balance Study of TS-142 in Healthy Adult Subjects.

Healthy Male Subjects

Japan
Connect Biopharma Australia Pty Ltd

Completed

Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults

Healthy Adult Subjects

Australia
Taiho Pharmaceutical Co., Ltd.

Completed

Mass Balance Study of [14C] TAS-205 in Healthy Volunteers

Healthy Male Subjects

Japan
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male Subjects

Healthy Male Subjects

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects

Healthy Male Subjects

China
Darnitsa Pharmaceutical Company
Anapharm Bioanalytics

Completed

Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Turkey
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Healthy Adult Subjects

China
Nobelpharma

Completed

A Study of NPC-22 in Healthy Adult Males

Healthy Adult Subjects

Japan
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects

Healthy Adult Subjects

China
Saniona

Completed

Study to Investigate the Pharmacokinetic Profile

Healthy Male Subjects

Germany
Bausch Health Americas, Inc.

Withdrawn

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

Methadone-maintenance Subjects

United States
Bausch Health Americas, Inc.

Completed

Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone

Metahdone-maintenance Subjects

United States
ARCIM Institute Academic Research in Complementary...
Universität Tübingen

Completed

Comparison of Pulse Wave and Blood Pressure Measurements Before, During and After Ergometry in Healthy Women

Healthy Female Subjects

Germany
Eli Lilly and Company
ARMO BioSciences

Completed

A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) (Willow 1)

Healthy Adult Subjects

United States
Exeltis France
Insud Pharma

Completed

Benznidazole Absorption, Metabolism and Excretion Study

Healthy Male Subjects

United Kingdom
HK inno.N Corporation

Completed

Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Healthy Male Subjects

Korea, Republic of
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Mass Balance Study of FYU-981

Healthy Male Subjects

Japan
Rigshospitalet, Denmark

Completed

Effect of Sodium Nitroprusside on Cerebral Blood Flow

Healthy Male Subjects

Denmark
AstraZeneca

Completed

A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects

Healthy Subjects | Pharmacodynamics

United Kingdom
Elysium Health
KGK Science Inc.

Completed

A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects. (15BSHE)

Safety: Healthy Subjects

Canada
Universidade Federal de Pernambuco

Unknown

Effects of Transcranial Direct Current Stimulation Associated With Physical Exercise: a Metaplasticity Study

Healthy Subjects | Metaplasticity

Brazil
Alcobra Ltd.

Completed

A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers

Healthy Adult Subjects

Israel

Clinical Trials on Volunteer Subjects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations